Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

4,731 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Safety and pharmacokinetics of oseltamivir at standard and high dosages.
Dutkowski R, Smith JR, Davies BE. Dutkowski R, et al. Int J Antimicrob Agents. 2010 May;35(5):461-7. doi: 10.1016/j.ijantimicag.2009.12.023. Epub 2010 Mar 1. Int J Antimicrob Agents. 2010. PMID: 20189775 Clinical Trial.
Safety profile of oseltamivir during the 2009 influenza pandemic.
Donner B, Bader-Weder S, Schwarz R, Peng MM, Smith JR, Niranjan V. Donner B, et al. Pharmacoepidemiol Drug Saf. 2011 May;20(5):532-43. doi: 10.1002/pds.2136. Pharmacoepidemiol Drug Saf. 2011. PMID: 21448900
The use of antiviral agents for the management of severe influenza.
Smith JR, Ariano RE, Toovey S. Smith JR, et al. Crit Care Med. 2010 Apr;38(4 Suppl):e43-51. doi: 10.1097/CCM.0b013e3181c85229. Crit Care Med. 2010. PMID: 19935416 Review.
A randomized, crossover study to evaluate the pharmacokinetics of amantadine and oseltamivir administered alone and in combination.
Morrison D, Roy S, Rayner C, Amer A, Howard D, Smith JR, Evans TG. Morrison D, et al. PLoS One. 2007 Dec 12;2(12):e1305. doi: 10.1371/journal.pone.0001305. PLoS One. 2007. PMID: 18074029 Free PMC article. Clinical Trial.
Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience.
Smith JR, Rayner CR, Donner B, Wollenhaupt M, Klumpp K, Dutkowski R. Smith JR, et al. Adv Ther. 2011 Nov;28(11):927-59. doi: 10.1007/s12325-011-0072-7. Epub 2011 Nov 1. Adv Ther. 2011. PMID: 22057727 Free PMC article. Review.
Oseltamivir in human avian influenza infection.
Smith JR. Smith JR. J Antimicrob Chemother. 2010 Apr;65 Suppl 2(Suppl 2):ii25-ii33. doi: 10.1093/jac/dkq013. J Antimicrob Chemother. 2010. PMID: 20215132 Free PMC article. Review.
Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.
Ward P, Small I, Smith J, Suter P, Dutkowski R. Ward P, et al. J Antimicrob Chemother. 2005 Feb;55 Suppl 1:i5-i21. doi: 10.1093/jac/dki018. J Antimicrob Chemother. 2005. PMID: 15709056 Review.
Pharmacokinetics of oseltamivir in young and very elderly subjects.
Abe M, Smith J, Urae A, Barrett J, Kinoshita H, Rayner CR. Abe M, et al. Ann Pharmacother. 2006 Oct;40(10):1724-30. doi: 10.1345/aph.1H174. Epub 2006 Aug 29. Ann Pharmacother. 2006. PMID: 16940405 Clinical Trial.
Active metabolite from Tamiflu solution is bioequivalent to that from capsule delivery in healthy volunteers: a cross-over, randomised, open-label study.
Brewster M, Smith JR, Dutkowski R, Robson R. Brewster M, et al. Vaccine. 2006 Nov 10;24(44-46):6660-3. doi: 10.1016/j.vaccine.2006.05.080. Epub 2006 Jun 9. Vaccine. 2006. PMID: 16797800 Clinical Trial.
4,731 results
Jump to page